aoki takahiro 青木孝浩

… Alternative Names

Aoki Takahiro 青木孝浩

Less

Researcher Number	30791553
Other IDs	https://orcid.org/0000-0002-9148-2871
Affiliation (Current)	2026: 千葉大学, 大学院医学研究院, 助教
Affiliation (based on the past Project Information) *help	2026: 千葉大学, 大学院医学研究院, 助教 2022 – 2023: 千葉大学, 大学院医学研究院, 助教 2020 – 2021: 国立研究開発法人理化学研究所, 生命医科学研究センター, 特別研究員 2019: 帝京大学, 医学部, 助教 2018: 千葉大学, 医学部附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator NKT細胞 / iPS細胞 / NK受容体 / 白血病 / 免疫療法 / iPS-NKT細胞 / がん免疫 / 認識分子 / CRISPR library / 腫瘍認識分子 / CRISPRライブラリー / iNKT細胞 / CD1d

iPS細胞由来NKT細胞を利用した腫瘍特異的T細胞養子免疫療法の開発Principal Investigator
- Principal Investigator
  
  青木孝浩
- Project Period (FY)
  2026 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Chiba University
Combination therapy of iPS-NKT cells and alpha-GalCer-pulsed antigen-presenting cells for leukemiaPrincipal Investigator
- Principal Investigator
  
  青木孝浩
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Chiba University
Identification of molecules recognized by invariant NKT cells independently of CD1dPrincipal Investigator
- Principal Investigator
  
  Aoki Takahiro
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Chiba University
  Institute of Physical and Chemical Research
Tumor recognition mechanism of NKT cells for CD1d-negative leukemia cellsPrincipal Investigator
- Principal Investigator
  
  Aoki Takahiro
- Project Period (FY)
  2018 – 2019
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Teikyo University
  Chiba University

All 2024 2023 2022 2020 2019

All Journal Article Presentation

[Journal Article] Progress in Natural Killer T Cell-Based Immunotherapy for Cancer: Use of Allogeneic and Gene-Edited Cells2024
- Author(s)
  Aoki Takahiro、Motohashi Shinichiro
- Journal Title
  
  Critical Reviews in Oncogenesis
  
  Volume: 29 Issue: 1 Pages: 1-9
- DOI
  10.1615/critrevoncog.2023049526
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24441, KAKENHI-PROJECT-23K07827
[Journal Article] 臨床開発ステージに進んだ新たながん免疫療法 iPS細胞由来NKT細胞を用いた免疫療法2023
- Author(s)
  青木孝浩、本橋新一郎
- Journal Title
  
  腫瘍内科
  
  Volume: 31 Pages: 334-340
- Data Source
  KAKENHI-PROJECT-23K07827
[Journal Article] Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy2023
- Author(s)
  Aoki Takahiro、Motohashi Shinichiro、Koseki Haruhiko
- Journal Title
  
  Inflammation and Regeneration
  
  Volume: 43 Issue: 1 Pages: 27-27
- DOI
  10.1186/s41232-023-00275-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K24441, KAKENHI-PROJECT-23K07827
[Journal Article] 他家NKT 細胞を用いた免疫細胞療法の開発2023
- Author(s)
  青木孝浩、本橋新一郎
- Journal Title
  
  癌と化学療法
  
  Volume: 50 Pages: 584-588
- Data Source
  KAKENHI-PROJECT-23K07827
[Journal Article] iPS細胞由来NKT細胞を利用したがん免疫療法2022
- Author(s)
  青木孝浩、本橋新一郎
- Journal Title
  
  Medical Technology
  
  Volume: 50 Pages: 1164-1166
- Data Source
  KAKENHI-PROJECT-20K17408
[Journal Article] 細胞療法の新しい戦略　幹細胞ベース　iPS細胞由来NKT細胞2020
- Author(s)
  青木孝浩、古関明彦
- Journal Title
  
  実験医学
  
  Volume: 38 Pages: 2956-2962
- Data Source
  KAKENHI-PROJECT-20K17408
[Journal Article] 再生医療の応用による免疫リプログラミング　iPS細胞を用いたNKT細胞再生と治療2020
- Author(s)
  青木孝浩、古関明彦
- Journal Title
  
  医学のあゆみ
  
  Volume: 275 Pages: 67-72
- Data Source
  KAKENHI-PROJECT-20K17408
[Presentation] Activation of iPS cell-derived NKT cells demonstrates indirect cytotoxicity by inducing stem-like T cells2024
- Author(s)
  Takahiro Aoki
- Organizer
  CD1-MR1 workshop
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K07827
[Presentation] Development of iPS cell-derived NKT cell therapy for regenerating the adjuvant effect2024
- Author(s)
  古関明彦、青木孝浩
- Organizer
  日本再生医療学会
- Invited
- Data Source
  KAKENHI-PROJECT-23K07827
[Presentation] iPS cell-derived NKT cells retain the adjuvant activity of inducing memory phenotype T cells2024
- Author(s)
  青木孝浩
- Organizer
  日本免疫学会
- Data Source
  KAKENHI-PROJECT-23K07827
[Presentation] iPS cell-derived NKT cells show indirect anti-tumor effect with inducing tumor-reactive T cells with memory phenotype2023
- Author(s)
  青木孝浩
- Organizer
  日本がん免疫学会
- Data Source
  KAKENHI-PROJECT-23K07827
[Presentation] Preclinical efficacy of iPS cell-derived NKT cell therapy with alpha-galactosylceramide-loaded antigen-presenting cells2023
- Author(s)
  青木孝浩
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-23K07827
[Presentation] Alpha-galactosylceramide-loaded antigen-presenting cells induce direct cytotoxicity and adjuvant effects of induced pluripotent stem cell-derived natural killer T cells2022
- Author(s)
  Takahiro Aoki, Genta Kitahara, Momoko Okoshi, Midori Kobayashi, Munechika Yamaguchi, Hiroko Okura, Nayuta Yakushiji, Masami Kawamura, Tomonori Iyoda, Kanako Shimizu, Shin-ichiro Fujii, Shinichiro Motohashi, Haruhiko Koseki
- Organizer
  Japanese Society for Immunology
- Data Source
  KAKENHI-PROJECT-20K17408
[Presentation] The iPS cell-derived NKT cell therapy with aGalCer-loaded dendritic cells for solid tumors2022
- Author(s)
  Takahiro Aoki, Genta Kitahara, Midori Kobayashi, Momoko Okoshi, Munechika Yamaguchi, Hiroko Okura, Nayuta Yakushiji, Masami Kawamura, Tomonori Iyoda, Kanako Shimizu, Shin-ichiro Fujii, Shinichiro Motohashi, Haruhiko Koseki
- Organizer
  Japanese Society for Transplantation and Cellular Therapy
- Data Source
  KAKENHI-PROJECT-20K17408
[Presentation] Invariant NKT cells target CD1d-negative leukemia cells with TCR and NK receptors.2019
- Author(s)
  Takahiro Aoki, Mariko Takami, Tomozumi Takatani, Kiwamu Motoyoshi, Ayana Ishii, Reona Okada, Moeko Hino, Naoki Shimojo, Shinichiro Motohashi.
- Organizer
  EMBO Workshop - CD1-MR1.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K16108
[Presentation] Invariant NKT Cells Recognize Leukemia Cells with T-Cell and NK Receptors in a CD1d-Independent Manner.2019
- Author(s)
  Takahiro Aoki, Mariko Takami, Tomozumi Takatani, Kiwamu Motoyoshi, Ayana Ishii, Ayaka Hara, Takahide Toyoda, Reona Okada, Moeko Hino, Ryo Koyama-Nasu, Masahiro Kiuchi, Kiyoshi Hirahara, Toshinori Nakayama, Naoki Shimojo, Shinichiro Motohashi.
- Organizer
  The 61th ASH annual meeting and exposition.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K16108
[Presentation] Invariant NKT cellsrecognize leukemia cells in a CD1d independent manner.2019
- Author(s)
  Takahiro Aoki, Mariko Takami, Tomozumi Takatani, Kiwamu Motoyoshi, Ayana Ishii, Reona Okada, Moeko Hino, Naoki Shimojo, Shinichiro Motohashi.
- Organizer
  第23回日本がん免疫学会総会.
- Data Source
  KAKENHI-PROJECT-18K16108

1. MOTOHASHI Shinichiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

aoki takahiro 青木 孝浩

Aoki Takahiro 青木 孝浩

Research Projects

Research Products

Co-Researchers

iPS細胞由来NKT細胞を利用した腫瘍特異的T細胞養子免疫療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Combination therapy of iPS-NKT cells and alpha-GalCer-pulsed antigen-presenting cells for leukemiaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of molecules recognized by invariant NKT cells independently of CD1dPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Tumor recognition mechanism of NKT cells for CD1d-negative leukemia cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Progress in Natural Killer T Cell-Based Immunotherapy for Cancer: Use of Allogeneic and Gene-Edited Cells2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 臨床開発ステージに進んだ新たながん免疫療法 iPS細胞由来NKT細胞を用いた免疫療法2023

Author(s)

Journal Title

Data Source

[Journal Article] Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 他家NKT 細胞を用いた免疫細胞療法の開発2023

Author(s)

Journal Title

Data Source

[Journal Article] iPS細胞由来NKT細胞を利用したがん免疫療法2022

Author(s)

Journal Title

Data Source

[Journal Article] 細胞療法の新しい戦略 幹細胞ベース iPS細胞由来NKT細胞2020

Author(s)

Journal Title

Data Source

[Journal Article] 再生医療の応用による免疫リプログラミング iPS細胞を用いたNKT細胞再生と治療2020

Author(s)

Journal Title

Data Source

[Presentation] Activation of iPS cell-derived NKT cells demonstrates indirect cytotoxicity by inducing stem-like T cells2024

Author(s)

Organizer

Data Source

[Presentation] Development of iPS cell-derived NKT cell therapy for regenerating the adjuvant effect2024

Author(s)

Organizer

Data Source

[Presentation] iPS cell-derived NKT cells retain the adjuvant activity of inducing memory phenotype T cells2024

Author(s)

Organizer

Data Source

[Presentation] iPS cell-derived NKT cells show indirect anti-tumor effect with inducing tumor-reactive T cells with memory phenotype2023

Author(s)

Organizer

Data Source

[Presentation] Preclinical efficacy of iPS cell-derived NKT cell therapy with alpha-galactosylceramide-loaded antigen-presenting cells2023

Author(s)

Organizer

Data Source

[Presentation] Alpha-galactosylceramide-loaded antigen-presenting cells induce direct cytotoxicity and adjuvant effects of induced pluripotent stem cell-derived natural killer T cells2022

aoki takahiro 青木孝浩

Aoki Takahiro 青木孝浩

[Journal Article] 細胞療法の新しい戦略　幹細胞ベース　iPS細胞由来NKT細胞2020

[Journal Article] 再生医療の応用による免疫リプログラミング　iPS細胞を用いたNKT細胞再生と治療2020